Viridian Therapeutics, Inc.\DE financial data

Symbol
VRDN on Nasdaq
Location
221 Crescent Street, Suite 103 A, Waltham, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.38K % -26.8%
Debt-to-equity 11.7 % +22%
Return On Equity -52.7 % -15.8%
Return On Assets -47.1 % -13.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 95.4M shares +20.5%
Common Stock, Shares, Outstanding 82.2M shares +3.85%
Entity Public Float 732M USD -28.3%
Common Stock, Value, Issued 822K USD +3.79%
Weighted Average Number of Shares Outstanding, Basic 66.4M shares +52.1%
Weighted Average Number of Shares Outstanding, Diluted 66.4M shares +52.1%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 77.2M USD -1.61%
Operating Income (Loss) -328M USD -15.9%
Nonoperating Income (Expense) 26.1M USD +0.72%
Net Income (Loss) Attributable to Parent -302M USD -17.5%
Earnings Per Share, Basic -4 USD/shares +16%
Earnings Per Share, Diluted -4 USD/shares +16%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash, Cash Equivalents, and Short-term Investments 491M USD -34.8%
Assets, Current 572M USD -25.5%
Property, Plant and Equipment, Net 1.13M USD -12.8%
Operating Lease, Right-of-Use Asset 2.58M USD +7.58%
Other Assets, Noncurrent 1.52M USD +78%
Assets 577M USD -25.2%
Accounts Payable, Current 10.1M USD +58.8%
Employee-related Liabilities, Current 10.7M USD +7.02%
Accrued Liabilities, Current 40.6M USD +17%
Contract with Customer, Liability, Current 372K USD +29.2%
Liabilities, Current 50.7M USD +22.6%
Contract with Customer, Liability, Noncurrent 140K USD -67.3%
Operating Lease, Liability, Noncurrent 2.2M USD 0%
Other Liabilities, Noncurrent 2.58M USD +19.5%
Liabilities 74.2M USD +15.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 363K USD -61.1%
Retained Earnings (Accumulated Deficit) -1.22B USD -33%
Stockholders' Equity Attributable to Parent 503M USD -28.9%
Liabilities and Equity 577M USD -25.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -92.7M USD -105%
Net Cash Provided by (Used in) Financing Activities 9.21M USD -94.8%
Net Cash Provided by (Used in) Investing Activities 100M USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 82.2M shares +3.85%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 16.6M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 170M USD -15.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 448K USD -0.89%
Deferred Tax Assets, Valuation Allowance 209M USD +33.9%
Deferred Tax Assets, Gross 209M USD +33.9%
Operating Lease, Liability 2.89M USD +4.91%
Payments to Acquire Property, Plant, and Equipment 86K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -303M USD -18.1%
Lessee, Operating Lease, Liability, to be Paid 3.4M USD +1.28%
Property, Plant and Equipment, Gross 2.5M USD -8.05%
Operating Lease, Liability, Current 730K USD +23.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 836K USD +11.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 965K USD +33.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 511K USD -15.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 854K USD +39.3%
Deferred Tax Assets, Operating Loss Carryforwards 77.4M USD +14.3%
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 505K USD -19.5%
Additional Paid in Capital 1.53B USD +6.84%
Depreciation, Depletion and Amortization 117K USD -19.3%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 41.3M USD -30.3%
Interest Expense 700K USD 0%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%